ACM
SUPN icon

AUA Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

AUA Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33
Closed -$1K – 353
2021
Q2 		$1K Buy
33
+8
+32% +$245 ﹤0.01% 325
2021
Q1 		$1K Sell
25
-63
-72% -$1.76K ﹤0.01% 334
2020
Q4 		$2K Buy
88
+12
+16% +$258 ﹤0.01% 282
2020
Q3 		$2K Buy
+76
New +$1.73K ﹤0.01% 252

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

AUA Capital Management's SUPN Position: Q3 2021 in Review

AUA Capital Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2021, closing a stake of 33 shares — an estimated $1K sold.

AUA Capital Management first reported a position in SUPN in Q3 2020 and held it in 4 quarters. The position peaked at $2K in Q4 2020. 223 funds tracked by Wall St. Rank hold SUPN as of Q3 2021.

  • AUA Capital Management reported no remaining Supernus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • AUA Capital Management sold 33 Supernus Pharmaceuticals shares in Q3 2021, an estimated $1K.
  • AUA Capital Management first reported a position in Supernus Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • AUA Capital Management's Supernus Pharmaceuticals position peaked at $2K in Q4 2020.
  • 223 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2021.

Based on AUA Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.